DeMuth Peter — SEC Form 4 filings

SEC reporting owner CIK 1979163. 7 Form 4 filings on record with FilingPulse; latest filed 2026-07-17.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2024-02-05 to 2026-07-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Elicio Therapeutics, Inc. (ELTX)Chief Scientific Officer711

Form 4 filings — DeMuth Peter

FiledFormIssuerReported transactionsSource
2026-07-174Elicio Therapeutics, Inc. (ELTX)Grant/award (A): 52,832 (derivative) @ $0EDGAR
2026-02-034Elicio Therapeutics, Inc. (ELTX)Grant/award (A): 20,800 @ $0 · Grant/award (A): 41,600 (derivative) @ $0EDGAR
2025-12-104Elicio Therapeutics, Inc. (ELTX)Option exercise (M): 362 @ $4.41 · Option exercise (M): 362 (derivative) @ $0EDGAR
2025-02-044Elicio Therapeutics, Inc. (ELTX)Grant/award (A): 44,400 (derivative) @ $0EDGAR
2024-12-184Elicio Therapeutics, Inc. (ELTX)Option exercise (M): 381 @ $4.41 · Option exercise (M): 381 (derivative) @ $0EDGAR
2024-10-024Elicio Therapeutics, Inc. (ELTX)Grant/award (A): 29,800 (derivative) @ $0EDGAR
2024-02-054Elicio Therapeutics, Inc. (ELTX)Grant/award (A): 29,800 (derivative) @ $0 · Grant/award (A): 342 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1979163 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →